Promotions & Moves

Mereo BioPharma Appoints Head of Pharma Development

Richard Francis brings more than 35 years of experience in biopharmaceutical process development and manufacturing operations

Mereo BioPharma Group plc has appointed Richard Francis as head of Pharmaceutical Development, effective August 1, 2019. Mr. Francis brings more than 35 years of experience in biopharmaceutical process development and manufacturing operations across a diverse set of product types including antibodies, recombinant DNA proteins, gene therapy constructs and at all stages of their life cycle development.   Dr. Denise Scots-Knight, chief executive officer of Mereo BioPharma commented, “Richard’s ex...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters